Introduction {#sec1_1}
============

Hereditary renal hypouricemia is an autosomal recessive disease characterized by hypouricemia with hyper-uric acid clearance. This disease is divided into two groups, based on the presence of mutations in the *SLC22A12* gene. Type 1 is caused by a loss-of-function mutation in the *SLC22A12* gene encoding the urate transporter 1 (URAT1) \[[@B1]\]. Type 2 is derived from defects in the *SLC2A9* gene encoding the glucose transporter 9 (GLUT9) \[[@B2]\] (Fig. [1](#F1){ref-type="fig"}).

While most patients are asymptomatic, episodes of the urolithiasis and exercise-induced acute kidney injury (EAKI) are sometimes observed \[[@B3], [@B4]\]. The increased risk of urolithiasis is due to hyperuricosuria and hypercalciuria \[[@B5]\]. Furthermore, the pathogenesis of EAKI remains unclear. Acute uric acid nephropathy as a consequence of the increased production of uric acid during exercise-induced ATP degradation, and vasoconstriction and ischemia in response to oxidative stress from oxygen-free radicals have been proposed as causes of the renal injury \[[@B3], [@B6]\]. It has been speculated that severe hypouricemia increases the risk of reduced kidney function through antioxidant potential, since uric acid is one of the most important antioxidants in human plasma \[[@B7], [@B8]\].

Since past AKI episodes have been closely related to the development of chronic kidney disease, the prevention of recurrent EAKI is crucial for patients with hereditary renal hypouricemia \[[@B9]\]. Although the most effective approach to prevention is avoiding anaerobic exercise, many kinds of jobs require physical activities. Herein, we present a case of a young EAKI patient with hereditary renal hypouricemia who worked as a police officer. It was difficult to develop a preventive plan for his return to work. Although the number of reports of EAKI in hereditary renal hypouricemia patients are increasing, job-related EAKI and its prevention have been rarely discussed.

Case Report {#sec1_2}
===========

A 27-year-old male was referred to our hospital by a family doctor due to nausea, headache, low back pain, and elevated serum creatinine. The patient was a police officer working in a regional police station. He noted the symptoms after a 20-m multistage shuttle run test as part of his occupational physical training. In brief, this test consisted of continuous running back and forth between two lines, 20 m apart, within a given time interval. The participants had to keep running between the two lines and turning when signaled by the beeps. The time was shortened every minute, increasing the speed by 0.5 km/h from a starting speed of 8.5 km/h. (Fig. [2](#F2){ref-type="fig"}). \[[@B10]\]. The patient had exhibited no serious illnesses except for usual childhood diseases until adulthood. He only consumed alcohol on social occasions -- up to a bottle of beer. He was not a smoker. His mother was diagnosed as having renal hypouricemia and his grandmother had died from renal failure. The mother\'s serum uric acid concentration was maintained below 2.0 mg/dL. Laboratory data could not be obtained from the other family members. The patient was reported to exhibit hypouricemia during a regular medical checkup.

The patient was of average build and well nourished but appeared to be in some discomfort. There were no significant abnormalities on physical examination. Urinalysis showed a ± dipstick test for protein and negative for sugar. The urinary protein-to-creatinine ratio was 0.22 g/g creatinine. Laboratory tests revealed a serum urea nitrogen of 50.9 mg/dL (normal values: 9--21), creatinine level of 4.89 mg/dL (0.4--0.9) and eGFR of 13.3 mL/min/1.73 m^2^, indicating stage 3 AKI (KDIGO). The hematologic evaluation, biological tests including creatine phosphokinase and uric acid, and serological tests were all within normal ranges (Table [1](#T1){ref-type="table"}). Abdominal computed tomography (CT) scan revealed no morphological abnormalities in the kidneys and urinary tracts (Fig. [3](#F3){ref-type="fig"}).

Since the fractional excretion of sodium was 0.4%, we diagnosed pre-renal AKI due to volume depletion after exercise. We performed drip infusion and ordered the patient to rest and avoid strenuous physical activities. One month later, the urinary findings and renal function returned to normal. The serum uric acid was 0.5 mg/dL and fractional excretion of uric acid was 82%, suggesting that he was also exhibiting renal hypouricemia and that this episode was due to EAKI in hereditary renal hypouricemia \[[@B4]\].

The patient and his family strongly desired for him to keep his career. While the best way for the patient to avoid the recurrence of AKI was to avoid anaerobic exercise, he had to return to physical training. We advised him to drink a sufficient volume of water before and after the exercise and to stop training as soon as he experienced nausea or back pain. We also explained the patient\'s risk of AKI to his director and requested that arrangements be made to control the nature and level of exercise. Since then, he has been able to manage his risk and there have been no further episodes of AKI.

Discussion {#sec1_3}
==========

The incidence of hypouricemia in Japan has been reported to be 0.12--0.19% \[[@B11], [@B12]\], and hypouricemia is associated with reduced kidney function \[[@B7]\]. Hypouricemia is also associated with a history of kidney disease, especially in males \[[@B12]\]. It is considered that these phenomena are caused by recurrent EAKI and urinary stones \[[@B12]\].

Many jobs, such as police officers, soldiers, and professional athletes, require strenuous physical exercise. Japanese police officers have to maintain and improve their physical abilities pre- and post-employment \[[@B13]\]. Their physical abilities are subsequently checked at regular intervals \[[@B14]\]. The 20-m shuttle run test, which triggered EAKI in our patient, is included among the evaluation items \[[@B14]\]. While the 20-m shuttle run test was designed to measure aerobic fitness by predicting the maximum oxygen uptake and performance, it is known that the test is a better predictor for running performance and optimal training intensity \[[@B15], [@B16]\]. The score is likely influenced by anaerobic power and capacity \[[@B16]\]. Every police officer must undergo regular health checks. While serum uric acid is regularly measured as part of the health check, hypouricemia at a younger age tends to be missed since its aim is mainly to differentiate those who have hyperuricemia among the middle-aged and elderly.

The most critical point was for our patient to maintain his career without recurrence of EAKI. In addition to our patient, there have been two reports of EAKI in a Japanese sumo wrestler and a professional cyclist \[[@B17], [@B18]\]. The 18-year-old Japanese sumo wrestler was advised to warm up before exercise and he subsequently did not experience any similar episodes, even though the hypouricemia (0.8--1.0 mg/dL) persisted; however, the "warm up" method was not described in detail \[[@B17]\]. Renal blood flow does not change significantly after mild exercise compared with at rest \[[@B19]\], and low-volume sprint exercise increases plasma catalase activity, one of the antioxidative enzymes \[[@B20]\]. Long-term regular moderate exercise training shifts the redox balance towards a reducing environment \[[@B21]\]. An 18-year-old professional trainee cyclist with EAKI was diagnosed as having "acute renal failure with severe loin pain and patchy renal ischemia after anaerobic exercise" (ALPE) \[[@B18]\]. Although 51% of ALPE cases have been reported to involve patients with renal hypouricemia, his serum uric acid was within the normal range \[[@B22]\]. This trainee was told to avoid physical exercise when he was sick, dehydrated, or taking medications, and he ultimately made his debut as a professional cyclist and continued his career without relapse for more than 3 years \[[@B18]\]. We advised our patient to consume a sufficient volume of fluids before and after exercise, since his fractional excretion of sodium was below 1%, indicating that volume depletion played a key role in the AKI, and to discontinue exercise when he felt nausea or low back pain, as observed in this episode. Although prevention of the recurrence of EAKI was favored, further prophylaxis was advised to be considered if he underwent relapse. Allopurinol, which inhibits uric acid production, would be one candidate. It has been shown that administration of 300 mg allopurinol to 5 renal hypouricemia patients prevented EAKI, as well as exercise-induced increases in uric acid excretion \[[@B23]\]. The rationale for the use of allopurinol in hypouricemic patients is to decrease the generation of uric acid and filtered uric acid load during exercise \[[@B23]\]. Moreover, allopurinol also exhibits an antioxidant property through the inhibition of xanthine oxidase, an important biological source of free radicals \[[@B24]\].

Although the patient\'s hypouricemia had been reported previously and the patient\'s mother had been diagnosed as having hereditary hypouricemia, he did not know the risk of EAKI. If the patient\'s risk had been shared with the doctor who had diagnosed his mother as well as the doctor managing the health check in the police, this episode could have been avoided.

It was difficult to make the patient\'s director accommodate his exercise regimen since the relationship between EAKI and hereditary renal hypouricemia have not been well established in the community. It is beneficial to inform people that serum uric acid levels are risk markers of gout (at high levels) as well as EAKI (at low levels), especially when physical activity is required. When we diagnosed the patient as having EAKI, the clinical presentation strikingly suggested ALPE \[[@B25]\]. It was preferable to perform contrast media-enhanced CT, in order to identify severe vasoconstriction in the kidneys as wedge-shaped defects. Since he had stage 3 AKI (KDIGO), we did not attempt to perform enhanced CT and selected the term "EAKI" \[[@B4], [@B25]\].

Recent studies have shown that elevated uric acid is not only an indicator of cardiovascular and kidney disease, but also a true indicator or mediator of the etiology \[[@B8]\]. Based upon clinical and experimental data, uric acid appears to play a dual role, with both pro- and antioxidant activities \[[@B8]\]. Intracellular uric acid generally imposes harmful effects, as a pro-oxidant, in cultured cells and in animal models of hyperuricemia, supported by the protective effects of an inhibitor of the organic anion transporter, which blocks the entry of uric acid into the cells, and the amelioration of oxidative stress \[[@B26]\]. On the other hand, according to a hypothesis by Ames et al. \[[@B27]\], silencing of the uricase gene with increased serum uric acid levels in humans provided an evolutional advantage for our ancestors. This hypothesis is based upon the findings of in vitro studies demonstrating uric acid as a powerful scavenger of free radicals and as a chelator of transitional metal ions in sera \[[@B27]\]. The paradoxical roles of uric acid are possibly regulated in different compartments of the body \[[@B8]\]. Thus, it is suggested that hypouricemia directly connects to the loss of antioxidant activity, leading to vascular and renal damage \[[@B7], [@B8], [@B28]\] (Fig. [4](#F4){ref-type="fig"}).

Conclusion {#sec1_4}
==========

Patients with hereditary renal hypouricemia who are required to be engaged in occupational exercise have a higher risk of EAKI than other workers. Serum uric acid levels should be focused on at both higher and lower values compared with the normal range. It is necessary to consider the risks and the design of any preventive plan for EAKI.
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![Pathophysiological model of renal hypouricemia at the proximal tubules. **a** Pathophysiological model of renal hypouricemia type 1. **b** Pathophysiological model of renal hypouricemia type 2.](cnd-0009-0092-g01){#F1}

![The 20-m multistage shuttle run test. The participant continues to run back and forth between two lines, 20 m apart, within the interval of the beeps and has to increase the running speed gradually.](cnd-0009-0092-g02){#F2}

![Abdominal CT image of the patient (non-enhanced). CT image of the patient shows no evidence of urolithiasis or hydronephrosis. The size and shape of both kidneys are normal.](cnd-0009-0092-g03){#F3}

![Putative pathogenesis of EAKI. Strenuous exercise induces massive reactive oxygen species (ROS) which overcomes anti-oxidative activity of uric acid. Vascular constriction and endothelial damages play a key role in the development of AKI.](cnd-0009-0092-g04){#F4}

###### 

Results of the laboratory tests

  Urinalysis                   First visit   1 month later   Normal range   Chemistry                First visit   1 month later   Normal range   
  ---------------------------- ------------- --------------- -------------- ------------------------ ------------- --------------- -------------- --
  SG                           1.008         1.014           1.015--1.025   TP, g/dL                 7             nd              6.3--7.8       
  PH                           5.5           7               5.0--7.8       Alb, g/dL                4.2           nd              3.7--4.9       
  Protein                      (±)           (−)             (−)            AST, IU/L                11            16              11--40         
  Occult blood                 (−)           (−)             (−)            ALT, IU/L                7             14              6--43          
  Glucose                      (−)           (−)             (−)            LDH, U/L                 152           169             200--400       
  RBC, *n*/HPF                 \<1           \<1             \<1            CK, IU/L                 62            77              57--197        
  WBC, *n*/HPF                 1--4          \<1             \<1--3         BUN, mg/dL               50.9          13.6            9--21          
                                                                            Cr, mg/dL                4.89          0.79            0.4--0.9       
  Hyaline casts, *n*/WF        (−)           (−)             \<1--2         eGFR, mL/min/1.73 m^2^   13.3          97.5            \>60           
  Granular casts,              (−)           (−)             (−)            UA, mg/dL                2.8           0.5             3.8--7.5       
  Protein, g/gCr               0.22          0               \<0.05         Na, mEq/L                139           143             135--145       
  NAG, IU/L                    8.2           nd              0.7--11.2      K, mEq/L                 4.2           4.2             3.5--4.9       
  β~2~-- microglobulin, µg/L   487           nd              \< 230         Cl, mEq/L                102           106             96--108        
                                                                            Ca, mg/dL                9.7           nd              8.5--10.5      
  *Peripheral blood*                                                        P, mg/dL                 4.3           nd              2.5--4.5       
  WBC, *n*/µL                  5,400         5,700           4700--8700     CRP, mg/dL               1.1           nd              \<0.5          
  RBC, ×10^4^/µL               455           445             427--500       HbA1c, %                 5.1           nd              \<5.8          
  Hb, g/dL                     14            13.8            13.5--17.6     FT3, pg/mL               2.1           nd              2.2--4.3       
  Ht, %                        42            40.3            39.8--51.8     FT4, ng/mL               1.2           nd              0.8--1.6       
  PLT, ×l0^4^/µL               22.9          23.6            15--35         TSH, µIU/mL              1.34          nd              0.2--4.5       
                                                                            BNP, pg/mL               38.8          nd              \<18.4         
  *Serology*                                                                *Fractional excretion*                                                
  ANA                          320X          nd              (−)                                     Admission     1 month                        
                                                                                                                   later                          
  IgG, mg/dL                   1,092         nd              739--1649      Na, %                    0.4           1.1                            
  IgA, mg/dL                   184           nd              107--363       UN, %                    36            38                             
  IgM, mg/dL                   240           nd              46--260        UA, %                    nd            82                             
  C3, mg/dL                    84.9          nd              65--135                                                                              
  C4, mg/dL                    28.5          nd              13--35                                                                               
  CH50, U/mL                   45            nd              28--53                                                                               
  Cryoglobulin                 (−)           nd              (−)                                                                                  
  MPO--ANCA,                   EU            \<10            nd             \<10                                                                  
  PR3--ANCA,                   EU            \<10            nd             \<10                                                                  

nd, not done.
